A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted

NCT01775189 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ALO-02 weight-matched placebo
DRUG: crushed ALO-02 30 mg/3.6 mg
DRUG: oxycodone weight-matched placebo
DRUG: crushed oxycodone IR 30 mg

Sponsor

Pfizer

Collaborators

[object Object]